RecruitingNANCT06136221

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Sponsor: University of Pennsylvania

Trial Details

ConditionCirrhosis, Liver, End Stage Liver DIsease, Symptoms and Signs, Physical Inactivity, Muscle Loss
InterventionLiverWatch Intervention
PhaseNA
StatusRecruiting
Participants110
Est. Completion30 June 2026
Last Updated11 May 2026

Primary Outcome

PROMIS 29+2

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * English speaking * Aged 18 years or older * Home-dwelling * Diagnosis of cirrhosis- Child Turcotte-Pugh (CTP) B or C or a complication in the past 6 months (CTP B or higher, hepatic encephalopathy, variceal bleeding, fluid overload, liver-related hospitalization, or requiring symptom management with diuretics, non-absorbable disaccharides, rifaximin, nonselective beta blockers) * Patient and/or caregiver is able and willing to receive SMS text messages * Willing and able to wear personal fitness trackers and engage with study staff Exclusion Criteria: * No access to a smartphone * Non-home dwelling * On hospice care * Model for end stage liver disease (MELD) score ≥30 * Advanced hepatocellular carcinoma, BCLC C or higher * Hospitalization within the last 30 days * Deemed not appropriate by treating physician for medical reasons * Enrolled in other dietary or physical activity interventions * Receiving physical therapy as standard of care

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service